FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Advanced Pharmaceutical Technology Testo-200 Recall

TESTO-200, Testosterone Cypionate Inj

Advanced Pharmaceutical Technology, Inc. · Elmsford, NY

Risk level
Class II
Reported by FDA
Jul 2, 2025
Recall ID
D-0531-2025
Check your lot numberHow we source this data

Summary

Advanced Pharmaceutical Technology recalled Testo-200 starting May 30, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0531-2025 on Jul 2, 2025. Reason: Marketed Without an Approved NDA/ANDA. Status: Ongoing.

Why it was recalled

Marketed Without an Approved NDA/ANDA

Product description

TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523. NDC 57377-200-01

Lot numbers, UPCs & expiration codes

Lot P-24-1; Exp. 02/28/2027

Where it was sold

NY, NJ

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0531-2025
Classification
Class II
Status
Ongoing
Recall initiated
May 30, 2025
FDA report date
Jul 2, 2025
Quantity
26 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Advanced Pharmaceutical Technology, Inc.

Original FDA data

Every field from FDA enforcement report D-0531-2025, exactly as published.

Show all FDA fields
City
Elmsford
State
NY
Status
Ongoing
Country
United States
Event ID
96981
Address
132 S Central Ave
Code information
Lot P-24-1; Exp. 02/28/2027
Postal code
10523-3509
Report date
Jul 2, 2025
Product type
Drugs
Recall number
D-0531-2025
Classification
Class II
Recalling firm
Advanced Pharmaceutical Technology, Inc.
Product quantity
26 vials
Reason for recall
Marketed Without an Approved NDA/ANDA
Voluntary / mandated
Voluntary: Firm initiated
Product description
TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523. NDC 57377-200-01
Distribution pattern
NY, NJ
Recall initiation date
May 30, 2025
Initial firm notification
Letter
Center classification date
Jul 16, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0531-2025, published Jul 2, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls